Delivery Order SPE2DB20D2104-SPE2DB22FS39T
Award Date 4/13/22
Potential Completion Date 4/14/22
Potential Value $5.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of pharmaceutical products, specifically Gemtesa 75 mg tablets, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,133.49 and an ultimate completion date of October 12, 2022. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,623.50, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,340.41 firm fixed-price delivery order is for the supply of Gemtesa 75 mg tablets. The contract has a completion date of July 17, 2024 and was awarded on July 16, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,354.31, is for the delivery of Gemtesa 75 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Gemtesa 75 mg tablets in 30-count packages. The $2,302.81 firm-fixed-price delivery order was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 13, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 5, 2024, with a ceiling value of $23,911.17 and a completion date of February 6, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Gemtesa 75 mg tablets. The $1,738.98 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 31, 2022. The contract is not designated as a set-aside. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and...
- This federal contract award, valued at $1,942.34, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the drug Gemtesa 75 mg Tablet, and is a firm fixed-price delivery order with an ultimate completion date of November 15, 2022. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $2,703.14, is for the delivery of Gemtesa 75 mg tablets. This contract is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of...
- This federal contract award, valued at $1,033.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 30S, a medical product, with a completion date of February 24, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...